Anand Mehra, Director at Aclaris Therapeutics, Inc. (ACRS), bought 744,186 shares at $10.75 ($8.0M) on 2018-10-22, disclosed to the SEC on 2018-10-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.75 | 372,093 | $4.0M | 50.0% |
| 2 | $10.75 | 372,093 | $4.0M | 50.0% |
| Total | $10.75 avg | 744,186 | $8.0M | 100% |
| Filing → |
| ONCE | SELL | 2017-06-22 | $410K | — | Filing → |
| ONCE | SELL | 2017-03-06 | $2.0M | — | Filing → |
| ONCE | SELL | 2017-03-01 | $11.0M | — | Filing → |